An Asymptomatic SARS-CoV-2-Infected Infant With Persistent Fecal Viral RNA Shedding in a Family Cluster: A Rare Case Report

Shen Chen, Jiafeng Si, Wenqiang Tang, Anqi Zhang, Pan Li, Meng An, Huawei Zhang, Shoukun Xue, Kunpeng Wu, Shuangfeng Chen, Wei Zhang, Wei Liu, Bo FuFrontiers in Medicine 2020 · DOI

Abstract

An outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become pandemic worldwide. A better understanding of asymptomatic infections is crucial to prevent and control of this epidemic. Here, we report the epidemiological and clinical characteristics of a family cluster with SARS-CoV-2 infection. In the family cluster, a 32-year-old male (case 1) and a 53-year-old female (case 2) exhibited clinical symptoms of COVID-19, while case 1’s 32-year-old wife (case 3) and their 11-month-old daughter (case 4) were both asymptomatic. Notably, case 4’s nasopharyngeal swab samples turned negative for nearly 80 days, but the fecal samples tested positive for 100 days (as of May 13, 2020), suggesting SARS-CoV-2 may invade enterocytes and persist in individuals with low antiviral immunity for a long term. This report highlights that asymptomatic infections should be managed with caution and vigilance.

Introduction

Early in the COVID-19 pandemic, public health efforts focused primarily on symptomatic respiratory transmission. However, asymptomatic carriers—individuals who harbor the virus without clinical illness—presented a significant challenge for surveillance and containment. A critical unknown was the duration and route of viral shedding in these individuals, particularly in children. While nasopharyngeal swabs were the standard diagnostic tool, emerging evidence suggested the gastrointestinal tract could serve as a viral reservoir. This study investigates a family cluster to elucidate the "concealment" of SARS-CoV-2 in the gut and the potential for long-term environmental contamination from asymptomatic pediatric patients.

Methods

The study involved a longitudinal clinical analysis of a family cluster of four individuals in Liaocheng, China. The methodology included:

  • Epidemiological Tracking: Mapping exposure timelines and symptom onset following travel from Wuhan.
  • Viral Detection: Serial RT-PCR testing of nasopharyngeal swabs and fecal samples to monitor viral RNA shedding.
  • Clinical Imaging: Chest CT scans to evaluate pulmonary involvement.
  • Laboratory Analysis: Monitoring of routine blood markers (leukocytes, neutrophils, lymphocytes) and C-reactive protein (CRP).
  • Immunological Profiling: For the infant (Case 4), flow cytometry measured NK cells, B cells, and T-cell subtypes, alongside SARS-CoV-2 specific IgG antibody testing.

Results

The study followed four family members: Case 1 (32-year-old male, symptomatic), Case 2 (53-year-old female, symptomatic), Case 3 (32-year-old female, asymptomatic), and Case 4 (11-month-old female, asymptomatic infant).

Timeline of SARS-CoV-2 exposure, symptom onset, and viral shedding across the family cluster.

Clinical and Radiographic Divergence

A clear distinction was observed between symptomatic and asymptomatic members. Cases 1 and 2 presented with classic COVID-19 symptoms (fever, cough) and characteristic "ground-glass opacities" on chest CT scans. In contrast, the mother (Case 3) and infant (Case 4) remained asymptomatic with entirely clear CT scans throughout the observation period.

Chest CT scans of the four cases, showing ground-glass opacities in symptomatic adults (A, B) and clear lungs in asymptomatic individuals (C, D).

Persistent Fecal Shedding in the Infant

The most significant finding was the prolonged viral shedding in Case 4. While the infant's nasopharyngeal swabs turned negative after 22 days, her fecal samples remained positive for 100 days. This represents one of the longest documented instances of viral RNA shedding in an asymptomatic carrier. Despite being asymptomatic, the infant exhibited an active immune response, with significantly elevated lymphocytes (9.27 × 10⁹/L) and detectable specific IgG antibodies by day 57.

Discussion and Conclusion

The disconnect between respiratory and gastrointestinal viral clearance suggests that SARS-CoV-2 effectively invades enterocytes, which express high levels of the ACE2 receptor. The infant's ability to carry the virus for 100 days without symptoms may be due to "immune tolerance," where an immature immune system avoids the inflammatory "cytokine storm" seen in severe adult cases.

These findings indicate that asymptomatic individuals, especially children, may pose a persistent transmission risk via the fecal-oral route long after respiratory clearance. Consequently, discharge protocols should consider mandatory negative fecal tests in addition to respiratory swabs to ensure complete viral clearance. While this single family case report requires validation through larger cohorts, it underscores the need for vigilance in managing asymptomatic pediatric infections.

Summary updated

Abstract

An outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become pandemic worldwide. A better understanding of asymptomatic infections is crucial to prevent and control of this epidemic. Here, we report the epidemiological and clinical characteristics of a family cluster with SARS-CoV-2 infection. In the family cluster, a 32-year-old male (case 1) and a 53-year-old female (case 2, the mother-in-law of case 1) exhibited clinical symptoms of COVID-19, while case 1’s 32-year-old wife (case 3) and their 11-month-old daughter (case 4) were both asymptomatic. Notably, case 4’s nasopharyngeal swab samples turned negative for nearly 80 days, and her immune system has been boosted for at least 57 days, but the fecal samples have been tested positive for 100 days (May 13, 2020), suggesting SARS-CoV-2 may invade enterocytes and may exist in individuals with low antiviral immunity for a long term. This report highlights that asymptomatic infections should be managed with caution and vigilance. For SARS-CoV-2 test of asymptomatic cases, besides the normally used nasopharyngeal swab, the fecal sample-testing is also needed.
BibTeX
@inproceedings{chen2020asymptomatic,
  author = {Shen Chen and Jiafeng Si and Wenqiang Tang and Anqi Zhang and Pan Li and Meng An and Huawei Zhang and Shoukun Xue and Kunpeng Wu and Shuangfeng Chen and Wei Zhang and Wei Liu and Bo Fu},
  title = {{An Asymptomatic SARS-CoV-2-Infected Infant With Persistent Fecal Viral RNA Shedding in a Family Cluster: A Rare Case Report}},
  booktitle = {Frontiers in Medicine},
  year = {2020},
  doi = {10.3389/fmed.2020.562875},
}
Figure